Tatva Chintan Pharma Chem Ltd

BOM:543321 (India)  
₹ 986.55 (+1.49%) Sep 20
85.68
P/B:
3.07
Market Cap:
₹ 23.08B ($ 276.44M)
Enterprise V:
₹ 22.76B ($ 272.68M)
Volume:
5.14K
Avg Vol (2M):
4.50K
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Tatva Chintan Pharma Chem Ltd ( ) from 2021 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Tatva Chintan Pharma Chem stock (BOM:543321) PE ratio as of Sep 21 2024 is 85.68. More Details

Tatva Chintan Pharma Chem Ltd (BOM:543321) PE Ratio (TTM) Chart

To

Tatva Chintan Pharma Chem Ltd (BOM:543321) PE Ratio (TTM) Historical Data

Total 784
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 9
Tatva Chintan Pharma Chem PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-21 87.5 2024-07-19 95.6
2024-09-20 87.5 2024-07-18 99.4
2024-09-19 86.3 2024-07-16 104.0
2024-09-18 87.1 2024-07-15 103.4
2024-09-17 88.3 2024-07-12 102.2
2024-09-16 86.4 2024-07-11 102.3
2024-09-13 86.4 2024-07-10 102.9
2024-09-12 86.0 2024-07-09 103.3
2024-09-11 85.6 2024-07-08 102.9
2024-09-10 85.9 2024-07-05 103.7
2024-09-09 85.4 2024-07-04 103.0
2024-09-06 86.3 2024-07-03 100.5
2024-09-05 86.6 2024-07-02 100.5
2024-09-04 87.2 2024-07-01 100.8
2024-09-03 87.8 2024-06-28 98.2
2024-09-02 86.9 2024-06-27 82.6
2024-08-30 85.0 2024-06-26 84.5
2024-08-29 86.2 2024-06-25 84.3
2024-08-28 87.7 2024-06-24 84.9
2024-08-27 88.5 2024-06-21 83.4
2024-08-26 88.8 2024-06-20 83.3
2024-08-23 91.0 2024-06-19 81.6
2024-08-22 91.2 2024-06-18 82.6
2024-08-21 91.3 2024-06-14 76.5
2024-08-20 87.7 2024-06-13 76.5
2024-08-19 86.8 2024-06-12 76.5
2024-08-16 85.5 2024-06-11 75.8
2024-08-14 84.4 2024-06-10 75.7
2024-08-13 85.1 2024-06-07 77.1
2024-08-12 86.8 2024-06-06 76.2
2024-08-09 87.7 2024-06-05 72.4
2024-08-08 85.7 2024-06-04 74.7
2024-08-07 86.6 2024-06-03 76.6
2024-08-06 85.0 2024-05-31 77.6
2024-08-05 86.2 2024-05-29 80.7
2024-08-02 88.3 2024-05-28 81.0
2024-08-01 88.2 2024-05-27 80.5
2024-07-31 88.6 2024-05-24 82.3
2024-07-30 88.7 2024-05-23 83.8
2024-07-29 88.8 2024-05-22 84.0
2024-07-26 88.7 2024-05-21 81.6
2024-07-25 88.0 2024-05-17 82.5
2024-07-24 95.1 2024-05-16 82.0
2024-07-23 96.0 2024-05-15 82.6
2024-07-22 95.5 2024-05-14 82.0

Tatva Chintan Pharma Chem Ltd (BOM:543321) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.